GM602
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GM602, covering 2019-08-12 to 2019-08-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours [Phase 2]